Foghorn Therapeutics Inc. (NASDAQ:FHTX) Just Reported, And Analysts Assigned A US$11.67 Price Target [Yahoo! Finance]
Foghorn Therapeutics Inc. (FHTX)
Company Research
Source: Yahoo! Finance
The early response was not positive, with shares down 2.1% to US$5.98 in the past week. Statutory results overall were mixed, with revenues coming in 31% lower than the analysts predicted. What's really surprising is that losses of US$0.59 per share were 66% smaller than what was predicted. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year. See our latest analysis for Foghorn Therapeutics Taking into account the latest results, the current consensus, from the five analysts covering Foghorn Therapeutics, is for revenues of US$24.2m in 2024. This implies a disturbing 29% reduction in Foghorn Therapeutics' revenue over the past 12 months. Losses are forecast to narrow 8.1% to US$2.01 per share. Yet prior to the
Show less
Read more
Impact Snapshot
Event Time:
FHTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FHTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FHTX alerts
High impacting Foghorn Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
FHTX
News
- Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]Yahoo! Finance
- Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire
- Foghorn Therapeutics Inc. (NASDAQ: FHTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.MarketBeat
- Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update [Yahoo! Finance]Yahoo! Finance
FHTX
Earnings
- 8/4/23 - Beat
FHTX
Sec Filings
- 5/20/24 - Form 8-K
- 5/6/24 - Form 8-K
- 5/6/24 - Form 10-Q
- FHTX's page on the SEC website